Celgene Announces Presentations Of Investigational Studies In Solid Tumor And Blood Cancers At American Society of Clinical Oncology 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation (NASDAQ:CELG), today announced more than 65 abstracts reporting on investigational studies in blood and solid tumor cancers will be presented during the 50th American Society of Clinical Oncology meeting in Chicago, Ill. from May 30 to June 3, 2014.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC